← back to search

Hiroki Kabata

Keio University · JP
Area of research
Immunology · Physiology
Research interest
Research interests include Asthma and respiratory diseases, IL-33, ST2, and ILC Pathways, Eosinophilic Esophagitis, and Immune Cell Function and Interaction.
h-index
29
citations
5,819
works
122
NIH funding
primary concept
email

Recent publications

Deciphering state-dependent immune features from multi-layer omics data at single-cell resolution
Nature Genetics 2025cited by 7position: middledoi
Single-cell analyses and host genetics highlight the role of innate immune cells in COVID-19 severity
Nature Genetics 2023cited by 65position: middledoi
DOCK2 is involved in the host genetics and biology of severe COVID-19
Nature 2022cited by 95position: middledoi
The whole blood transcriptional regulation landscape in 465 COVID-19 infected samples from Japan COVID-19 Task Force
Nature Communications 2022cited by 49position: middledoi
Clinical Characteristics of Patients with Coronavirus Disease (COVID-19): Preliminary Baseline Report of Japan COVID-19 Task Force, a Nationwide Consortium to Investigate Host Genetics of COVID-19
International Journal of Infectious Diseases 2021cited by 58position: middledoi
Effectiveness of Face Masks in Preventing Airborne Transmission of SARS-CoV-2
mSphere 2020cited by 445position: middledoi
Targeted deletion of the TSLP receptor reveals cellular mechanisms that promote type 2 airway inflammation
Mucosal Immunology 2020cited by 94position: firstdoi
Innate lymphoid cells support regulatory T cells in the intestine through interleukin-2
Nature 2019cited by 287position: middledoi
Neuro-immune crosstalk and allergic inflammation
Journal of Clinical Investigation 2019cited by 201position: firstdoi
The group 2 innate lymphoid cell ( <scp>ILC</scp> 2) regulatory network and its underlying mechanisms
Immunological Reviews 2018cited by 276position: firstdoi
Response to Fungal Dysbiosis by Gut-Resident CX3CR1+ Mononuclear Phagocytes Aggravates Allergic Airway Disease
Cell Host & Microbe 2018cited by 123position: middledoi
The neuropeptide neuromedin U stimulates innate lymphoid cells and type 2 inflammation
Nature 2017cited by 540position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

David Artis · Cornell University4 papers (2017–2020)Gregory Putzel · NYU Langone Health3 papers (2017–2019)Saya Moriyama · National Institute of Infectious Diseases2 papers (2017–2020)Anne-Laure Flamar · Cornell University2 papers (2017–2020)Tanel Mahlakõiv · Icosagen (Estonia)2 papers (2017–2020)Jesper B. Moeller · University of Southern Denmark1 papers (2017–2017)Coco Chu · Shanxi Medical University1 papers (2019–2019)Hans‐Reimer Rodewald · German Cancer Research Center1 papers (2020–2020)Iliyan D. Iliev · Cornell University1 papers (2018–2018)William D. Fiers · University of Minnesota1 papers (2018–2018) · 1 papers (2017–2017)Donna L. Färber · Columbia University Irving Medical Center1 papers (2017–2017)Masaki Imai · Gunma University1 papers (2020–2020)Amanda E. Ramer‐Tait · University of Nebraska Medical Center1 papers (2018–2018)Lei Zhou · Renji Hospital1 papers (2019–2019)Jérémy Goc · Cornell University1 papers (2019–2019)Yoshihiro Kawaoka · University of Wisconsin–Madison1 papers (2020–2020) · 1 papers (2018–2018)Yuri Furusawa · Mie Chuo Medical Center1 papers (2020–2020)Fei Teng · Cornell University1 papers (2019–2019)